Clinical Trials
4 trialsNCT00368875 2015-11-05
Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast Cancer
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT00132002 2015-03-19
Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast Cancer
National Cancer Institute (NCI)
Phase 2 Terminated
NCT00258349 2014-06-02
Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT00045006 2013-05-30
Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer
National Cancer Institute (NCI)
Phase 1 Completed